A tetrapeptide class of biased analgesics from an Australian fungus targets the µ-opioid receptor.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
29 10 2019
Historique:
pubmed: 16 10 2019
medline: 14 4 2020
entrez: 16 10 2019
Statut: ppublish

Résumé

An Australian estuarine isolate of

Identifiants

pubmed: 31611414
pii: 1908662116
doi: 10.1073/pnas.1908662116
pmc: PMC6825270
doi:

Substances chimiques

Analgesics, Opioid 0
Fungal Proteins 0
Oligopeptides 0
Receptors, Opioid, mu 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

22353-22358

Informations de copyright

Copyright © 2019 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

Competing interest statement: Patent Application(s) corresponding to Australian Patent Application 2018901944 The University of Sydney and The University of Queensland has been filed concerning this peptide. Title: Analgesics and Methods of Use Thereof.

Références

Sci Rep. 2017 Nov 13;7(1):15389
pubmed: 29133887
Cell. 2017 Jan 26;168(3):377-389.e12
pubmed: 28129538
PLoS One. 2010 May 06;5(5):e10512
pubmed: 20463905
Nature. 2015 Aug 20;524(7565):315-21
pubmed: 26245379
J Biol Chem. 2001 Apr 20;276(16):12774-80
pubmed: 11278523
Curr Opin Struct Biol. 2017 Aug;45:124-132
pubmed: 28482214
Angew Chem Int Ed Engl. 2015 Dec 21;54(52):15771-6
pubmed: 26568421
Nature. 1997 Apr 3;386(6624):499-502
pubmed: 9087409
J Pharmacol Exp Ther. 2003 Dec;307(3):947-54
pubmed: 14534366
J Nat Prod. 2007 Nov;70(11):1746-52
pubmed: 17958395
J Biol Chem. 1994 Apr 15;269(15):10967-70
pubmed: 8157620
Cell. 2017 Nov 16;171(5):1165-1175.e13
pubmed: 29149605
Mol Pharmacol. 2015 Aug;88(2):335-46
pubmed: 26013541
Curr Protoc Pharmacol. 2016 Sep 16;74:2.15.1-2.15.15
pubmed: 27636109
Br J Pharmacol. 1996 Dec;119(8):1614-8
pubmed: 8982509
J Mol Biol. 2017 Jun 16;429(12):1840-1851
pubmed: 28502792
Nature. 2018 Mar 1;555(7694):121-125
pubmed: 29466332
Int J High Perform Comput Appl. 2015 May;29(2):119-134
pubmed: 25972727
Science. 2012 Mar 2;335(6072):1106-10
pubmed: 22267580
Toxicol Rev. 2006;25(2):79-85
pubmed: 16958555
Mol Pharmacol. 2015 Oct;88(4):825-35
pubmed: 25969388
Annu Rev Pharmacol Toxicol. 1980;20:81-110
pubmed: 6247963
J Biol Chem. 2010 Apr 23;285(17):12522-35
pubmed: 20189994
Mol Pharmacol. 2010 Oct;78(4):756-66
pubmed: 20647394
Nat Chem Biol. 2018 Feb;14(2):126-134
pubmed: 29227473
Br J Pharmacol. 2018 Jul;175(13):2653-2661
pubmed: 29582414
Nature. 2012 Mar 21;485(7398):321-6
pubmed: 22437502
J Pharmacol Exp Ther. 2011 Feb;336(2):296-302
pubmed: 21030484
Physiol Rev. 2001 Jan;81(1):299-343
pubmed: 11152760
J Pharmacol Exp Ther. 2005 Sep;314(3):1195-201
pubmed: 15917400
Nat Rev Drug Discov. 2018 Apr;17(4):243-260
pubmed: 29302067
Mol Pharmacol. 2012 Aug;82(2):178-88
pubmed: 22553358
J Pain Res. 2017 Oct 06;10:2413-2424
pubmed: 29062240
J Pharmacol Exp Ther. 2013 Mar;344(3):708-17
pubmed: 23300227
Biochem Pharmacol. 2016 Aug 1;113:70-87
pubmed: 27286929
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W116-8
pubmed: 16844972
Br J Pharmacol. 2011 Sep;164(2):298-307
pubmed: 21449911
Int J Pept Protein Res. 1995 Jul;46(1):47-55
pubmed: 7558596
Future Med Chem. 2012 Feb;4(2):205-26
pubmed: 22300099
J Pharmacol Exp Ther. 1987 Oct;243(1):397-401
pubmed: 3668866
Nature. 1977 Aug 11;268(5620):547-9
pubmed: 196219
Br J Pharmacol. 2013 Aug;169(7):1430-46
pubmed: 23646826
Nature. 2018 Jun;558(7711):547-552
pubmed: 29899455
Chem Rev. 2017 Dec 27;117(24):14015-14041
pubmed: 29227635
Br J Pharmacol. 2015 Jan;172(2):460-8
pubmed: 24372103
Nature. 2016 Sep 8;537(7619):185-190
pubmed: 27533032
Proc Natl Acad Sci U S A. 1987 Aug;84(15):5487-91
pubmed: 2440052
Biochemistry. 2016 Nov 22;55(46):6456-6466
pubmed: 27778501
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7157-62
pubmed: 9618555
Nature. 1976 Apr 29;260(5554):795-7
pubmed: 1264259
JAMA. 2017 Dec 19;318(23):2295-2296
pubmed: 29049472
Peptides. 2018 Mar;101:227-233
pubmed: 29196181

Auteurs

Zoltan Dekan (Z)

Institute for Molecular Bioscience, The University of Queensland, 4072 Brisbane, Australia.

Setareh Sianati (S)

Discipline of Pharmacology, School of Medical Sciences, University of Sydney, NSW 2006, Australia.

Arsalan Yousuf (A)

Discipline of Pharmacology, School of Medical Sciences, University of Sydney, NSW 2006, Australia.

Katy J Sutcliffe (KJ)

Schools of Physiology, Pharmacology and Neuroscience, and Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, United Kingdom.

Alexander Gillis (A)

Discipline of Pharmacology, School of Medical Sciences, University of Sydney, NSW 2006, Australia.

Christophe Mallet (C)

Discipline of Pharmacology, School of Medical Sciences, University of Sydney, NSW 2006, Australia.

Paramjit Singh (P)

Institute for Molecular Bioscience, The University of Queensland, 4072 Brisbane, Australia.

Aihua H Jin (AH)

Institute for Molecular Bioscience, The University of Queensland, 4072 Brisbane, Australia.

Anna M Wang (AM)

Discipline of Pharmacology, School of Medical Sciences, University of Sydney, NSW 2006, Australia.

Sarasa A Mohammadi (SA)

Discipline of Pharmacology, School of Medical Sciences, University of Sydney, NSW 2006, Australia.

Michael Stewart (M)

Institute for Molecular Bioscience, The University of Queensland, 4072 Brisbane, Australia.

Ranjala Ratnayake (R)

Institute for Molecular Bioscience, The University of Queensland, 4072 Brisbane, Australia.

Frank Fontaine (F)

Institute for Molecular Bioscience, The University of Queensland, 4072 Brisbane, Australia.

Ernest Lacey (E)

Microbial Screening Technologies Pty. Ltd., Smithfield, NSW, 2164, Australia.

Andrew M Piggott (AM)

Institute for Molecular Bioscience, The University of Queensland, 4072 Brisbane, Australia.

Yan P Du (YP)

Discipline of Pharmacology, School of Medical Sciences, University of Sydney, NSW 2006, Australia.

Meritxell Canals (M)

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, 3052 Parkville, Australia.

Richard B Sessions (RB)

Schools of Physiology, Pharmacology and Neuroscience, and Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, United Kingdom.

Eamonn Kelly (E)

Schools of Physiology, Pharmacology and Neuroscience, and Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, United Kingdom.

Robert J Capon (RJ)

Institute for Molecular Bioscience, The University of Queensland, 4072 Brisbane, Australia; r.capon@imb.uq.edu.au p.alewood@imb.uq.edu.au mac.christie@sydney.edu.au.

Paul F Alewood (PF)

Institute for Molecular Bioscience, The University of Queensland, 4072 Brisbane, Australia; r.capon@imb.uq.edu.au p.alewood@imb.uq.edu.au mac.christie@sydney.edu.au.

MacDonald J Christie (MJ)

Discipline of Pharmacology, School of Medical Sciences, University of Sydney, NSW 2006, Australia; r.capon@imb.uq.edu.au p.alewood@imb.uq.edu.au mac.christie@sydney.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH